Table 2.
Characteristic | Hospital 8 (n = 55) | Hospital 10 (n = 101) | Hospital 19 (n = 61) | Hospital 20 (n = 87) | Hospital 26 (n = 90) | Other Hospitals (n = 190) | P Value |
---|---|---|---|---|---|---|---|
Male sex, % | 45 | 43 | 44 | 44 | 36 | 42 | .844 |
Urinary catheter use in past 30 d, % | 26 | 23 | 31 | 33 | 31 | 29 | .695 |
Age, y, mean (SD) | 71.44 (13.81) | 71.71 (12.62) | 73.61 (12.96) | 77.56 (9.21) | 79.8 (10.46) | 74.34 (11.88) | < .001 |
Physical self-maintenance scale, mean (SD) | 14.45 (5.06) | 14.01 (4.41) | 13.9 (4.09) | 13.98 (4.13) | 15.17 (4.79) | 14.28 (4.73) | .467 |
Length of hospital stay, d, mean (SD) | 7.84 (5.61) | 6.58 (5.12) | 7.9 (5.77) | 6.16 (5.3) | 6.9 (4.31) | 7.52 (9.16) | .478 |
Charlson comorbidity score, mean (SD) | 2.91 (1.89) | 3.39 (2.38) | 2.84 (1.9) | 2.13 (2.2) | 2.47 (1.97) | 2.23 (1.82) | < .001 |
Black race, % | 96 | 71 | 72 | 0 | 7 | 22 | < .001 |
Exposure to 1st/2nd-gen cephalosporins, % | 0 | 5 | 11 | 11 | 9 | 16 | .004 |
Exposure to 3rd/4th-gen cephalosporins, % | 11 | 18 | 23 | 11 | 13 | 11 | .145 |
Exposure to glycopeptides, % | 4 | 16 | 13 | 9 | 17 | 13 | .2 |
MRSA colonization at discharge, % | 9 | 11 | 13 | 7 | 12 | 14 | .662 |
VREfm colonization at discharge, % | 18 | 14 | 33 | 8 | 23 | 15 | .002 |
VREfc colonization at discharge, % | 5 | 8 | 7 | 6 | 11 | 10 | .67 |
CipREc colonization at discharge, % | 4 | 10 | 5 | 7 | 6 | 4 | .452 |
One-way analysis of variance was used to compare patient characteristics and antibiotic resistant–organism prevalence at different hospitals.
Abbreviations: CipREc, ciprofloxacin-resistant Escherichia coli; MRSA, methicillin-resistant Staphylococcus aureus; SD, standard deviation; VREfc, vancomycin-resistant Enterococcus faecalis; VREfm, vancomycin-resistant Enterococcus faecium.